The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Open accessAbstract
Natural killer (NK) cells are innate immune cells that show strong cytolytic function against physiologically stressed cells such as tumor cells and virus-infected cells. NK cells show a broad array of tissue distribution and phenotypic variability. NK cells express several activating and inhibitory receptors that recognize the altered expression of proteins on target cells and control the cytolytic function. NK cells have been used in several clinical trials to control tumor growth. However, the results are encouraging only in hematological malignancies but not very promising in solid tumors. Increasing evidence suggests that tumor microenvironment regulate the phenotype and function of NK cells. In this review, we discussed the NK cell phenotypes and its effector function and impact of the tumor microenvironment on effector and cytolytic function of NK cells. We also summarized various NK cell-based immunotherapeutic strategies used in the past and the possibilities to improve the function of NK cell for the better clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132327 · Cited by 2,653
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Miller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903
Up on the tightrope: natural killer cell activation and inhibition
Lanier, L. L. (2008) · Nature Immunology · doi:10.1038/ni1581 · Cited by 1,656
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
CD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J. M., & Altfeld, M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,410
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Romee, R., Rosario, M., Berrien-Elliott, M. M., Wagner, J. A., Jewell, B. A., Schappe, T., Leong, J. W., Abdel-Latif, S., Schneider, S. E., Willey, S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2341 · Cited by 942
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Fauriat, C., Long, E. O., Ljunggren, H.-G., & Bryceson, Y. T. (2010) · Blood · doi:10.1182/blood-2009-08-238469 · Cited by 891
Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H. (2000) · Nature Immunology · doi:10.1038/77793 · Cited by 878
Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030788 · Cited by 875
Bryceson, Y. T., March, M. E., Ljunggren, H.-G., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 863
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Death receptor-induced cell killing
Thorburn, A. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.08.007 · Cited by 791
Li, H., Han, Y., Guo, Q., Zhang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.240 · Cited by 777
Recognition of a virus-encoded ligand by a natural killer cell activation receptor
Smith, H. R. C., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V., Iizuka, K., Furukawa, H., Beckman, D. L., Pingel, J. T., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092258599 · Cited by 767
Natural Killer Cell Signaling Pathways
Vivier, E., Nunès, J. A., & Vély, F. (2004) · Science · doi:10.1126/science.1103478 · Cited by 751
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., & Brooks, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.813 · Cited by 727
How Do Cytotoxic Lymphocytes Kill Cancer Cells?
Martínez-Lostao, L., Anel, A., & Pardo, J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0685 · Cited by 717
Conlon, K. C., Lugli, E., Welles, H. C., Rosenberg, S. A., Fojo, A. T., Morris, J. C., Fleisher, T. A., Dubois, S. P., Perera, L. P., Stewart, D. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.3329 · Cited by 711
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80222-8 · Cited by 695
Paust, S., Gill, H. S., Wang, B.-Z., Flynn, M. P., Moseman, E. A., Senman, B., Szczepanik, M., Telenti, A., Askenase, P. W., Compans, R. W., et al. (2010) · Nature Immunology · doi:10.1038/ni.1953 · Cited by 694
Cytokine activation induces human memory-like NK cells
Romee, R., Schneider, S. E., Leong, J. W., Chase, J. M., Keppel, C. R., Sullivan, R. P., Cooper, M. A., & Fehniger, T. A. (2012) · Blood · doi:10.1182/blood-2012-04-419283 · Cited by 684
The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing
Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R., & Raulet, D. H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00333-3 · Cited by 647
Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., Lopez-Vergès, S., Lanier, L. L., Weisdorf, D., & Miller, J. S. (2012) · Blood · doi:10.1182/blood-2011-10-386995 · Cited by 630
Marçais, A., Cherfils-Vicini, J., Viant, C., Degouve, S., Viel, S., Fenis, A., Rabilloud, J., Mayol, K., Tavares, A., Bienvenu, J., et al. (2014) · Nature Immunology · doi:10.1038/ni.2936 · Cited by 614
Fernandez, N. C., Treiner, E., Vance, R. E., Jamieson, A. M., Lemieux, S., & Raulet, D. H. (2005) · Blood · doi:10.1182/blood-2004-08-3156 · Cited by 588
Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., MacGregor, D., Godfrey, D. I., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.755 · Cited by 576
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572
Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors
Lanier, L. L., Corliss, B., Wu, J., & Phillips, J. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80574-9 · Cited by 559
p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
Salih, H. R., Antropius, H., Gieseke, F., Lutz, S. Z., Kanz, L., Rammensee, H.-G., & Steinle, A. (2003) · Blood · doi:10.1182/blood-2003-01-0019 · Cited by 541
Yawata, M., Yawata, N., Draghi, M., Little, A.-M., Partheniou, F., & Parham, P. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051884 · Cited by 520
Pende, D., Rivera, P., Marcenaro, S., Chang, C., Biassoni, R., Conte, R., Kubin, M. Z., Cosman, D. J., Ferrone, S., Moretta, L., et al. (2002) · PubMed · Cited by 500
MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
Liao, N.-S., Bix, M., Zijlstra, M., Jaenisch, R., & Raulet, D. (1991) · Science · doi:10.1126/science.1853205 · Cited by 490
Effect of NKG2D ligand expression on host immune responses
Champsaur, M., & Lanier, L. L. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00893.x · Cited by 488
Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E., & Raulet, D. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1841 · Cited by 482
Specific and nonspecific NK cell activation during virus infection
Dokun, A. O., Kim, S., Smith, H. R. C., Kang, H.-S. P., Chu, D. T., & Yokoyama, W. M. (2001) · Nature Immunology · doi:10.1038/ni714 · Cited by 477
Parkhurst, M. R., Riley, J. P., Dudley, M. E., & Rosenberg, S. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1347 · Cited by 475
Takeda, K., Smyth, M. J., Cretney, E., Hayakawa, Y., Kayagaki, N., Yagita, H., & Okumura, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011171 · Cited by 465
Immune Surveillance Properties of Human NK Cell-Derived Exosomes
Lugini, L., Cecchetti, S., Huber, V., Luciani, F., Macchia, G., Spadaro, F., Paris, L., Abalsamo, L., Colone, M., Molinari, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101988 · Cited by 453
Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A. M., Hsia, J. K., Vivier, E., & Raulet, D. H. (2002) · Nature Immunology · doi:10.1038/ni858 · Cited by 452
Chu, J., Deng, Y., Benson, D. M., He, S., Hughes, T., Zhang, J., Peng, Y., Mao, H., Yi, L., Ghoshal, K., et al. (2014) · Leukemia · doi:10.1038/leu.2013.279 · Cited by 439
Viaud, S., Terme, M., Flament, C., Taieb, J., André, F., Novault, S., Escudier, B., Robert, C., Caillat-Zucman, S., Tursz, T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004942 · Cited by 437
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation
Gilfillan, S., Ho, E. L., Cella, M., Yokoyama, W. M., & Colonna, M. (2002) · Nature Immunology · doi:10.1038/ni857 · Cited by 437
Geller, M. A., Cooley, S., Judson, P. L., Ghebre, R., Carson, L. F., Argenta, P. A., Jonson, A. L., Panoskaltsis-Mortari, A., Curtsinger, J., McKenna, D., et al. (2011) · Cytotherapy · doi:10.3109/14653249.2010.515582 · Cited by 436
Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice
Bix, M., Liao, N.-S., Zijlstra, M., Loring, J., Jaenisch, R., & Raulet, D. (1991) · Nature · doi:10.1038/349329a0 · Cited by 431
Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
Ni, J., Miller, M., Stojanovic, A., Garbi, N., & Cerwenka, A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120944 · Cited by 419
Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
Curti, A., Ruggeri, L., D'Addio, A., Bontadini, A., Dan, E., Motta, M. R., Trabanelli, S., Giudice, V., Urbani, E., Martinelli, G., et al. (2011) · Blood · doi:10.1182/blood-2011-01-329508 · Cited by 406
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Zhang, C., Burger, M. C., Jennewein, L., Genßler, S., Schönfeld, K., Zeiner, P., Hattingen, E., Harter, P. N., Mittelbronn, M., Tonn, T., et al. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv375 · Cited by 388
Natural killer cells: definition of a cell type rather than a function
Lanier, L. L., Phillips, J. H., Hackett, J., Tutt, M., & Kumar, V (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.8.2745.a · Cited by 384
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J., Crowe, N. Y., & Godfrey, D. I. (2001) · International Immunology · doi:10.1093/intimm/13.4.459 · Cited by 379
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Wendel, M., Galani, I. E., Suri-Payer, E., & Cerwenka, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1440 · Cited by 378
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J. (2008) · International Immunology · doi:10.1093/intimm/dxn028 · Cited by 377
Cutting Edge: Priming of NK Cells by IL-18
Chaix, J., Tessmer, M. S., Hoebe, K., Fuséri, N., Ryffel, B., Dalod, M., Alexopoulou, L., Beutler, B., Brossay, L., Vivier, E., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1627 · Cited by 374
NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway
Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J., & Leibson, P. J. (2003) · Nature Immunology · doi:10.1038/ni929 · Cited by 374
Identification of committed NK cell progenitors in adult murine bone marrow
Rosmaraki, E. E., Douagi, I., Roth, C., Colucci, F., Cumano, A., & Di Santo, J. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200106)31:6<1900::aid-immu1900>3.0.co;2-m · Cited by 364
Immune cells in the placental bed
Bulmer, J. N., Williams, P. J., & Lash, G. E. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082763jb · Cited by 360
Cancer immunoediting by the innate immune system in the absence of adaptive immunity
O’Sullivan, T., Saddawi-Konefka, R., Vermi, W., Koebel, C. M., Arthur, C., White, J. M., Uppaluri, R., Andrews, D. M., Ngiow, S. F., Teng, M. W. L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112738 · Cited by 348
NKG2D function protects the host from tumor initiation
Smyth, M. J., Swann, J., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 342
Han, J., Chu, J., Keung Chan, W., Zhang, J., Wang, Y., Cohen, J. B., Victor, A., Meisen, W. H., Kim, S.-H., Grandi, P., et al. (2015) · Scientific Reports · doi:10.1038/srep11483 · Cited by 340
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Balsamo, M., Scordamaglia, F., Pietra, G., Manzini, C., Cantoni, C., Boitano, M., Queirolo, P., Vermi, W., Facchetti, F., Moretta, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906481106 · Cited by 330
Chang, Y.-H., Connolly, J., Shimasaki, N., Mimura, K., Kono, K., & Campana, D. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3558 · Cited by 329
Pietra, G., Manzini, C., Rivara, S., Vitale, M., Cantoni, C., Petretto, A., Balsamo, M., Conte, R., Benelli, R., Minghelli, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2544 · Cited by 324
Natural killer cells: definition of a cell type rather than a function.
Lanier, L. L., Phillips, J. H., Hackett, J., Tutt, M., & Kumar, V (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.9.2735 · Cited by 307
Cekic, C., Day, Y.-J., Sag, D., & Linden, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3583 · Cited by 304
Upshaw, J. L., Arneson, L. N., Schoon, R. A., Dick, C. J., Billadeau, D. D., & Leibson, P. J. (2006) · Nature Immunology · doi:10.1038/ni1325 · Cited by 300
Natural killer cell cytotoxicity: how do they pull the trigger?
Topham, N. J., & Hewitt, E. W. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03123.x · Cited by 298
Tangye, S. G., Lazetic, S., Woollatt, E., Sutherland, G. R., Lanier, L. L., & Phillips, J. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.6981 · Cited by 297
T cell migration in rheumatoid arthritis
Mellado, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00384 · Cited by 291
NK cell education: not an on-off switch but a tunable rheostat
Brodin, P., Kärre, K., & Höglund, P. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.01.006 · Cited by 288
Bryceson, Y. T., Ljunggren, H.-G., & Long, E. O. (2009) · Blood · doi:10.1182/blood-2009-01-201632 · Cited by 286
Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodríguez, A., Pérez‐Villar, J. J., Moretta, L., Moretta, A., & López‐Botet, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270230 · Cited by 281
DNAM-1 and PVR Regulate Monocyte Migration through Endothelial Junctions
Reymond, N., Imbert, A.-M., Devilard, E., Fabre, S., Chabannon, C., Xerri, L., Farnarier, C., Cantoni, C., Bottino, C., Moretta, A., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032206 · Cited by 279
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Vey, N., Bourhis, J.-H., Boissel, N., Bordessoule, D., Prebet, T., Charbonnier, A., Etienne, A., Andre, P., Romagne, F., Benson, D., et al. (2012) · Blood · doi:10.1182/blood-2012-06-437558 · Cited by 278
Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · PubMed · Cited by 277
Sutherland, C. L., Chalupny, N. J., Schooley, K., VandenBos, T., Kubin, M., & Cosman, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.671 · Cited by 276
King, A., Balendran, N., Wooding, P., Carter, N. P., & Loke, Y. W. (1991) · Journal of Immunology Research · doi:10.1155/1991/83493 · Cited by 276
Carayannopoulos, L. N., Naidenko, O. V., Fremont, D. H., & Yokoyama, W. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4079 · Cited by 274
Natural cytotoxicity receptors and their ligands
Kruse, P. H., Matta, J., Ugolini, S., & Vivier, E. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2013.98 · Cited by 273
Sakamoto, N., Ishikawa, T., Kokura, S., Okayama, T., Oka, K., Ideno, M., Sakai, F., Kato, A., Tanabe, M., Enoki, T., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0632-8 · Cited by 270
Jiang, H., Zhang, W., Shang, P., Zhang, H., Fu, W., Ye, F., Zeng, T., Huang, H., Zhang, X., Sun, W., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2013.12.001 · Cited by 267
Licensing of natural killer cells by self‐major histocompatibility complex class I
Yokoyama, W. M., & Kim, S. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00458.x · Cited by 259
Skov, S., Pedersen, M. T., Andresen, L., Thor Straten, P., Woetmann, A., & Ødum, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0599 · Cited by 259
Cutting Edge: Ly-49D and Ly-49H Associate with Mouse DAP12 and Form Activating Receptors
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.7 · Cited by 249
Stebbins, C. C., Watzl, C., Billadeau, D. D., Leibson, P. J., Burshtyn, D. N., & Long, E. O. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6291-6299.2003 · Cited by 245
Regulation of NK cell functions by TGF-β 1
Bellone, G., Aste-Amezaga, M., Trinchieri, G., & Rodeck, U. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1066 · Cited by 243
Negative Regulation of Immunoreceptor Signaling
Veillette, A., Latour, S., & Davidson, D. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.130710 · Cited by 242
Vance, R. E., Jamieson, A. M., & Raulet, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1801 · Cited by 238
Activation and self‐tolerance of natural killer cells
Gasser, S., & Raulet, D. H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00460.x · Cited by 233
Trzonkowski, P., Szmit, E., Myśliwska, J., Dobyszuk, A., & Myśliwski, A. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.04.003 · Cited by 223
Romanski, A., Uherek, C., Bug, G., Seifried, E., Klingemann, H., Wels, W. S., Ottmann, O. G., & Tonn, T. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12810 · Cited by 220
Cichocki, F., Cooley, S., Davis, Z., DeFor, T. E., Schlums, H., Zhang, B., Brunstein, C. G., Blazar, B. R., Wagner, J., Diamond, D. J., et al. (2016) · Leukemia · doi:10.1038/leu.2015.260 · Cited by 219
Abi-Rached, L., & Parham, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042558 · Cited by 211
DAP12-mediated Signal Transduction in Natural Killer Cells
McVicar, D. W., Taylor, L. S., Gosselin, P., Willette-Brown, J., Mikhael, A. I., Geahlen, R. L., Nakamura, M. C., Linnemeyer, P., Seaman, W. E., Anderson, S. K., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32934 · Cited by 211
Lee, K.-M., McNerney, M. E., Stepp, S. E., Mathew, P. A., Schatzle, J. D., Bennett, M., & Kumar, V. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031989 · Cited by 208
Altvater, B., Landmeier, S., Pscherer, S., Temme, J., Schweer, K., Kailayangiri, S., Campana, D., Juergens, H., Pule, M., & Rossig, C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2810 · Cited by 206
Garrity, D., Call, M. E., Feng, J., & Wucherpfennig, K. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502439102 · Cited by 205
Natural killer cell distribution and trafficking in human tissues
Carrega, P., & Ferlazzo, G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00347 · Cited by 201
A Central Role for Death Receptor-Mediated Apoptosis in the Rejection of Tumors by NK Cells
Screpanti, V., Wallin, R. P. A., Ljunggren, H.-G., & Grandien, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2068 · Cited by 201
Shah, N., Martin-Antonio, B., Yang, H., Ku, S., Lee, D. A., Cooper, L. J. N., Decker, W. K., Li, S., Robinson, S. N., Sekine, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076781 · Cited by 199
Baginska, J., Viry, E., Paggetti, J., Medves, S., Berchem, G., Moussay, E., & Janji, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00490 · Cited by 198
Hashimoto, W., Osaki, T., Okamura, H., Robbins, P. D., Kurimoto, M., Nagata, S., Lotze, M. T., & Tahara, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.583 · Cited by 196
MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese, M. A., Platten, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, F., Bühring, H. ‐., DICHGANS, J., Rammensee, H., Steinle, A., et al. (2003) · PubMed · Cited by 193
IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18
Cai, G., Kastelein, R. A., & Hunter, C. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<2658::aid-immu2658>3.0.co;2-g · Cited by 191
Esser, R., Müller, T., Stefes, D., Kloess, S., Seidel, D., Gillies, S. D., Aperlo‐Iffland, C., Huston, J. S., Uherek, C., Schönfeld, K., et al. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01343.x · Cited by 188
Oelsner, S., Friede, M. E., Zhang, C., Wagner, J., Badura, S., Bader, P., Ullrich, E., Ottmann, O. G., Klingemann, H., Tonn, T., et al. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2016.10.009 · Cited by 188
Herraiz, C., Calvo, F., Pandya, P., Cantelli, G., Rodriguez-Hernandez, I., Orgaz, J. L., Kang, N., Chu, T., Sahai, E., & Sanz-Moreno, V. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv289 · Cited by 180
Origin, phenotype and function of human natural killer cells in pregnancy
Vacca, P., Moretta, L., Moretta, A., & Mingari, M. C. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.013 · Cited by 171
Expression of Stress-induced MHC Class I Related Chain Molecules on Human Melanoma
Vetter, C. S., Groh, V., Straten, P. T., Spies, T., Bröcker, E.-B., & Becker, J. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01700.x · Cited by 171
Mouse Ly-49D Recognizes H-2Dd and Activates Natural Killer Cell Cytotoxicity
Nakamura, M. C., Linnemeyer, P., Niemi, E., Mason, L., Ortaldo, J., Ryan, J., & Seaman, W. (1999) · Journal of Experimental Medicine · doi:10.1084/jem.189.3.493 · Cited by 171
Perforin dependence of natural killer cell‐mediated tumor control in vivo
van den Broek, M. F., Kägi, D., Zinkernagel, R. M., & Hengartner, H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251246 · Cited by 171
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity
Diefenbach, A., Hsia, J. K., Hsiung, M. B., & Raulet, D. H. (2003) · European Journal of Immunology · doi:10.1002/immu.200310012 · Cited by 170
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
Smyth, M. J., Swann, J., Kelly, J. M., Cretney, E., Yokoyama, W. M., Diefenbach, A., Sayers, T. J., & Hayakawa, Y. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041522 · Cited by 169
Function of NKG2D in natural killer cell–mediated rejection of mouse bone marrow grafts
Ogasawara, K., Benjamin, J., Takaki, R., Phillips, J. H., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1236 · Cited by 169
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
Horng, T., Bezbradica, J. S., & Medzhitov, R. (2007) · Nature Immunology · doi:10.1038/ni1524 · Cited by 168
Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma
Gluck, W. L., Hurst, D., Yuen, A., Levine, A. M., Dayton, M. A., Gockerman, J. P., Lucas, J., Denis-Mize, K., Tong, B., Navis, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1087-3 · Cited by 166
Natural Killer Cells Produce T Cell–Recruiting Chemokines in Response to Antibody-Coated Tumor Cells
Roda, J. M., Parihar, R., Magro, C., Nuovo, G. J., Tridandapani, S., & Carson, W. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2429 · Cited by 165
Arase, N., Arase, H., Park, S. Y., Ohno, H., Ra, C., & Saito, T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.1957 · Cited by 163
Johansson, M., Bieberich, C., Jay, G., Kärre, K., & Höglund, P. (1997) · Journal of Experimental Medicine · doi:10.1084/jem.186.3.353 · Cited by 160
Kubin, M. Z., Cassiano, L., Chalupny, J., Chin, W., Cosman, D. J., Fanslow, W. C., Müllberg, J., Rousseau, A.-M., Ulrich, D., & Armitage, R. J. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200105)31:5<1428::aid-immu1428>3.0.co;2-4 · Cited by 156
NK cells and T cells cooperate during the clinical course of colorectal cancer
Sconocchia, G., Eppenberger, S., Spagnoli, G. C., Tornillo, L., Droeser, R. A., Caratelli, S., Ferrelli, F., Coppola, A., Arriga, R., Lauro, D., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.952197 · Cited by 156
Kim, P. S., Kwilas, A. R., Xu, W. V., Alter, S., Jeng, E. K., Wong, H. C., Schlom, J., & Hodge, J. W. (2016) · Oncotarget · doi:10.18632/oncotarget.7470 · Cited by 156
Bluman, E. M., Bartynski, K., Avalos, B. R., & Caligiuri, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118726 · Cited by 148
von Strandmann, E. P., Hansen, H. P., Reiners, K. S., Schnell, R., Borchmann, P., Merkert, S., Simhadri, V. R., Draube, A., Reiser, M., Purr, I., et al. (2005) · Blood · doi:10.1182/blood-2005-05-2177 · Cited by 147
A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
Korde, N., Carlsten, M., Lee, M.-J., Minter, A., Tan, E. M., Kwok, M., Manasanch, E. E., Bhutani, M., Tageja, N., Roschewski, M. J., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.103085 · Cited by 137
Dam, J., Guan, R., Natarajan, K., Dimasi, N., Chlewicki, L. K., Kranz, D. M., Schuck, P., Margulies, D. H., & Mariuzza, R. A. (2003) · Nature Immunology · doi:10.1038/ni1006 · Cited by 135
Shoae‐Hassani, A., Hamidieh, A. A., Behfar, M., Mohseni, R., Mortazavi‐Tabatabaei, S. A., & Asgharzadeh, S. (2017) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000179 · Cited by 133
IL-21 Enhances Tumor Rejection through a NKG2D-Dependent Mechanism
Takaki, R., Hayakawa, Y., Nelson, A., Sivakumar, P. V., Hughes, S. D., Smyth, M. J., & Lanier, L. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2167 · Cited by 130
Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control
Pardo, J., Balkow, S., Anel, A., & Simon, M. M. (2002) · European Journal of Immunology · Cited by 124
Frederiksen, K. S., Lundsgaard, D., Freeman, J. A., Hughes, S. D., Holm, T. L., Skrumsager, B. K., Petri, A., Hansen, L. T., McArthur, G. A., Davis, I. D., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0479-4 · Cited by 124
Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
George, T. C., Ortaldo, J., Lemieux, S., Kumar, V., & Bennett, M. (1999) · Journal of Immunology · doi:10.4049/jimmunol.163.4.1859 · Cited by 124
Keppel, M. P., Yang, L., & Cooper, M. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201742 · Cited by 112
Role of tumor necrosis factor superfamily in neuroinflammation and autoimmunity
Sonar, S. A., & Lal, G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00364 · Cited by 110
Self-citationTissue-resident natural killer cells and their potential diversity
Sojka, D. K., Tian, Z., & Yokoyama, W. M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.010 · Cited by 109
Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D
Zhang, C., Zhang, J., Niu, J., Zhou, Z., Zhang, J., & Tian, Z. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.06.004 · Cited by 108
Selective Induction of Expression of a Ligand for the NKG2D Receptor by Proteasome Inhibitors
Valés‐Gómez, M., Chisholm, S. E., Cassady-Cain, R. L., Roda‐Navarro, P., & Reyburn, H. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2973 · Cited by 106
Nguyen, S., Béziat, V., Dhédin, N., Kuentz, M., Vernant, J., Debré, P., & Vieillard, V. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.380 · Cited by 105
IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors
Bui, J. D., Carayannopoulos, L. N., Lanier, L. L., Yokoyama, W. M., & Schreiber, R. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.905 · Cited by 104
2B4-mediated activation of human natural killer cells
Tangye, S. G. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00076-6 · Cited by 101
Vaidya, S. V., Stepp, S. E., McNerney, M. E., Lee, J., Bennett, M., Lee, K., Stewart, C. L., Kumar, V., & Mathew, P. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.800 · Cited by 100
Ni, J., Hölsken, O., Miller, M., Hammer, Q., Luetke-Eversloh, M. V., Romagnani, C., & Cerwenka, A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1219009 · Cited by 97
Takada, A., Yoshida, S., Kajikawa, M., Miyatake, Y., Tomaru, U., Sakai, M., Chiba, H., Maenaka, K., Kohda, D., Fugo, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1678 · Cited by 91
Signaling through CD38 induces NK cell activation
Mallone, R., Funaro, A., Zubiaur, M., Baj, G., Ausiello, C. M., Tacchetti, C., Sancho, J., Grossi, C. E., & Malavasi, F. (2001) · International Immunology · doi:10.1093/intimm/13.4.397 · Cited by 90
Eissmann, P., Evans, J. H., Mehrabi, M., Rose, E. L., Nedvetzki, S., & Davis, D. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903985 · Cited by 87
Paul, S., Kulkarni, N., Shilpi, & Lal, G. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1235106 · Cited by 79
Self-citationOverview of the Killer Cell Immunoglobulin-Like Receptor System
Rajalingam, R. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-842-9_23 · Cited by 74
IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
McMichael, E. L., Jaime-Ramirez, A. C., Guenterberg, K. D., Luedke, E., Atwal, L. S., Campbell, A. R., Hu, Z., Tatum, A. S., Kondadasula, S. V., Mo, X., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0004 · Cited by 70
Zhang, C., Zhang, J., Sun, R., Feng, J., Wei, H., & Tian, Z. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.02.003 · Cited by 70
Majewska‐Szczepanik, M., Paust, S., von Andrian, U. H., Askenase, P. W., & Szczepanik, M. (2013) · Immunology · doi:10.1111/imm.12120 · Cited by 67
Regulation of ITAM-positive receptors: role of IL-12 and IL-18
Ortaldo, J. R., Winkler-Pickett, R. T., Wigginton, J. M., Horner, M., Bere, E. W., Mason, A. T., BHAT, N. K., Cherry, J. M., Sanford, M. E., Hodge, D. L., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1579 · Cited by 57
Song, H., Hur, D. Y., Kim, K.-E., Park, H., Kim, T. S., Kim, C.-W., Bang, S., & Cho, D.-H. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.09.002 · Cited by 55
Ly-49P Activates NK-Mediated Lysis by Recognizing H-2Dd 1
Silver, E. T., Gong, D.-W., Chang, C., Amrani, A., Santamaria, P., & Kane, K. (2000) · Journal of Immunology · doi:10.4049/jimmunol.165.4.1771 · Cited by 53
Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
Ochoa, M. C., Fioravanti, J., Rodríguez, I., Hervás‐Stubbs, S., Azpilikueta, A., Mazzolini, G. D., Gúrpide, A., Prìeto, J., Pardo, J., Berraondo, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2660 · Cited by 48
Silver, E. T., Gong, D.-W., Hazes, B., & Kane, K. (2001) · Journal of Immunology · doi:10.4049/jimmunol.166.4.2333 · Cited by 47
Rah, S., Kwak, J., Chung, Y., & Kim, U. (2015) · Scientific Reports · doi:10.1038/srep09482 · Cited by 44
Sague, S. L., Tato, C. M., Puré, E., & Hunter, C. A. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/107999004323065093 · Cited by 44
Kim, M., Kim, T.-J., Kim, H. M., Doh, J., & Lee, K. (2017) · Scientific Reports · doi:10.1038/srep40623 · Cited by 40
Veluchamy, J. P., Heeren, A. M., Spanholtz, J., van Eendenburg, J. D. H., Heideman, D. A. M., Kenter, G. G., Verheul, H. M. W., van der Vliet, H. J., Jordanova, E. S., & de Gruijl, T. D. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1919-1 · Cited by 37
Cho, D., Kim, T., Lee, W.-J., Hwang, Y.-I., Cho, H.-I., Han, H. J., Kim, D., Kwon, O., Park, H., & Houh, D. (2000) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5600685 · Cited by 28
NK Cells are Required for Costimulatory Blockade Induced Tolerance to Vascularized Allografts
van der Touw, W., Burrell, B. E., Lal, G., & Bromberg, J. S. (2012) · Transplantation · doi:10.1097/tp.0b013e318264d3c4 · Cited by 24
Self-citationRole of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage
Canossi, A., Aureli, A., Beato, T. D., Rossi, P., Franceschilli, L., Sanctis, F. D., Sileri, P., Lorenzo, N. D., Buonomo, O. C., Lauro, D., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1001-y · Cited by 12
Cited by
Zhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01143 · Cited by 940
“NK cells induce the destruction of stressed cells, cells infected by viruses or bacteria as well as tumor cells (133); this last action performed through their “killer” receptor (KIR) (134).”
BackgroundRedox regulation of the immune response
Morris, G., Gevezova, M., Sarafian, V., & Maes, M. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00902-0 · Cited by 575
Marin, D., Li, Y., Basar, R., Rafei, H., Daher, M., Dou, J., Mohanty, V., Dede, M., Nieto, Y., Uprety, N., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02785-8 · Cited by 516
Lipids in the tumor microenvironment: From cancer progression to treatment
Corn, K. C., Windham, M. A., & Rafat, M. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101055 · Cited by 469
Metadata
- Authors
- Paul, S., & Lal, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-09-13
- Volume
- 8
- Pages
- 1124-1124
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2756061744
- Cited by
- 825
- References
- 169
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.